4th Quarter - Termination Amendment

W STRATEGIES, LLC for HORIZON PHARMA USA, INC.

Firm
Client
Income
$20,000
Expenses
—
Terminated
Dec 31, 2015

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Termination Jan 20, 2016 $20,000 Replaced
4th Quarter - Termination Amendment (this page) Jan 20, 2016 $20,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 6: 21st Century Cures Act.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 6 (114th)

Taxation/Internal Revenue Code TAX

Monitored legislation efforts to reform the corporate tax system.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

H.R. 9: Innovation Act, including proposed changes to the Inter Partes Review (IPR) process at the Patent and Trademark Office (PTO).

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 9 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.